Comprehend Systems is a technology company.
Comprehend Systems has raised $45.0M across 4 funding rounds.
Key people at Comprehend Systems.
Comprehend Systems was founded in 2010 by Rick Morrison (Founder and CEO).
Comprehend Systems has raised $45.0M in total across 4 funding rounds.
Comprehend Systems was founded in 2010 by Rick Morrison (Founder and CEO).
Comprehend Systems has raised $45.0M in total across 4 funding rounds.
Comprehend Systems's investors include Azimuth Ventures, DST Global, Lightspeed Venture Partners, Seven Seven Six, Ulu Ventures, Y Combinator, Aaron Levie, Farzad Nazem, Nils Johnson, Band of Angels, Felicis Ventures, Okapi Venture Capital.
Comprehend Systems was a cloud-based technology company that built software for clinical trial data management and analytics, enabling life sciences organizations to unify, monitor, and analyze data from disparate sources in real-time.[1][2][3] It served clinical operations teams, data managers, monitors, and executives at sponsors and contract research organizations (CROs), solving key problems like siloed data access, slow insights, trial delays, safety risks, and cost overruns by providing AI-powered tools for risk detection, visualization, and reporting.[1][3][4] The platform improved trial speed, quality, and compliance, with features like dashboards, drill-down analytics, and integration with systems such as Medidata Rave and Oracle Clinical; it raised $65.28M before being acquired by Saama Technologies in 2019, forming a leading clinical analytics platform.[1][2][3]
Founded in 2010 in Redwood City, California, Comprehend Systems emerged from Y Combinator's Winter 2011 batch, led by founder and CEO Rick Morrison.[1][2] Morrison, with expertise in clinical operations software, recognized the frustration of research teams lacking easy analytics across fragmented data sources despite advanced systems like Medidata Rave.[4] Early traction came from its cloud-based Clinical Intelligence Platform, which offered rapid deployment (as fast as one day), security compliance (SSAE 16 Type II and 21 CFR Part 11), and tools for operational trends, safety monitoring, and cost savings, attracting investors like Sequoia Capital, Lightspeed Venture Partners, and Eminence Capital.[1][2][4] The company filed 6 patents, including on multi-source data schemas, underscoring its technical innovation in data unification.[1]
Comprehend rode the wave of cloud adoption and AI in clinical trials during the 2010s, addressing a market shift from on-premise systems to hosted analytics amid exploding trial complexity and data volumes.[4] Timing was ideal as sponsors sought faster drug development without heavy IT overhauls, fueled by regulatory pressures for risk-based monitoring and forces like rising CRO outsourcing.[1][3][7] It influenced the ecosystem by pioneering "clinical intelligence" platforms, enabling biopharma to cut costs and accelerate therapies—paving the way for consolidations like its 2019 Saama merger, which boosted AI-powered solutions in a sector now valued for real-time insights amid post-pandemic trial digitization.[3]
Post-2019 acquisition, Comprehend's technology lives on within Saama's expanded AI clinical analytics suite, likely powering ongoing innovations in unified data platforms for faster patient treatments.[3] Trends like advanced NLP (e.g., similar to AWS Comprehend Medical) and decentralized trials will amplify its legacy, evolving toward fully predictive, end-to-end clinical AI amid biopharma's push for efficiency.[8] As consolidation continues, its influence could grow through Saama's ecosystem, redefining how life sciences turn disparate data into rapid, quality-driven insights—echoing its founding mission to empower ClinOps teams.
Key people at Comprehend Systems.
Comprehend Systems has raised $45.0M across 4 funding rounds. Most recently, it raised $15.0M Series C in February 2017.
